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My inves tigations "vere carried out with the object 
of d e termining the antifibrillatory adion of several 
medicaments, and ulso whether the antifibrilIatory 
udion wus present h e fore or after the appearance of 
the first toxic symptoms. . 
A commencement was ma de with the foJIowing Bar­
hituric acid preparations: VeronaJ-Sodium , Dial. Per­
nocton, Somnifen and Evipun-Sodium. 
Van Dongen v,;as unnhle to find any influen ce what­
ever on fibril/ution aher the lise of these subs tances . 
in th e five experime nts which I carried out with 
Ve ron a I-S 0 diu m the values for post-fibrillation 
came to zero in three cases, after a gradual fall had 
first :nade itself evident. 
In two of these three CClses th e values for Fibrillation 
a lso came to zero, so thaI it complete thera pe utic effect 
would h a ve been attained if no dilcd il tion of the ven­
tricle s had occurred b efore thn t time. A toxic injury 
to the heart had therefore lal,en place. The therapeutic 
dose was therefore lnrger thnn the maximum dose. 
I therefore found , in contrast with Van Dongen's 
res ults, a n antif'ibrillatory e ffect, a lthough the drug, as 
Fl specifi ca lly a ntifibrillatory drug , was found to be too 
toxic. 
Pe r n 0 C ton sho\\ccl n decline to zero of the values 
for post-fibrilla tion in only one of the five tests. 
In every case the d ecline was very rapid, and accom­
panied by an equally rapid inloxication ,of the heart. 




With So m n i fen a fall to ze ro ,va s attained i.n 

four of the fiv e posl-t'ihrilla tion cases, both for fihril­

lation a nd post-fihrillation . 

In the fifth experiment only th e vaiue for fibrillation of 

the righ t fl uriclc re rtwine d above ze ro. 
There wa s th e re lore an fllllilil)J'i1lillory action in thi s 
case also. but as the thc rareuli c e Heet first made its 
appearance after dilatatioll o f ttl!; vcntricics. the Ihcru ­
peuticCi/ dose vvas hi gllel' th a n tllf' maxim urn dose and 
tbe drug tl te rdore too toxi c. 
o i a I showed a fa ll or the vaiucs lor pos t-Fibrillatioll 
to zero in three 01 the fiv e cases , but only ilfter th e 
cardiac ilel ion had becorn e Lad C\ considerable tirn e 
hefore. Th.e drug is pre tty toxi c for tLe heart and so 
bu s no specifically Clnti-fibrillnting properties. 
The las t of th e B a rbituric acid prepara tions which 1 in­
vestiga ted ~or antifibrillatillg properties wa s E vip a n­
So d i u m. This drug showed in one case a fall of the 
values for pos t-fibrillati on to zero. 1n th e oth e r cases a 
slight £nil occurred only for post-fibrillation, whilst the 
va lue s for fibrillation re mained pra ctica lly constant. 
lVloreover only a t most five inj ections w ere re quired 
to reach the lethal dose. The anti-hbrillatory action is 
there fore in this case pure ly n result of th e intoxication 
of the heart. 
The Bnrbituric acid prep a ra tioll s which I investi ga ted 
there fore possess antifibrdJatory properties, but a re on 
the other h a nd too loxi c to b e used as a the rape utic 
drug. as in everv wse the the ra pe utic do se is above 
th e maximnm dose. 
Van Dongen found an nnti-hbrillatory action alte r th e 
u se of L u min a I, and attributed this probably to the 
influence of th e phenyl group which L II min a j con­
tai.ns. H e there fore inves tiga ted Ant i p Y r i n e and 
P y ram i don. which also co nta ill a phenyl group. 
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H e was. h oweve r, un a ble to tra ce a ny e ffect of these 
la tte r subs ta nce~ on fibr illa ti on . 
In the fi ve' e xpe riments wlli ch J ca rri ed out with Ant 1­
p Y r in the values fo r fibrill a ti on a nd post-f'ibrill a tion 
cume in four cases to ze ro, n h e r th e occurre nce of a 
sl(n\' and rc gulHr £nil of' n li tI le vu Jues. so tha t a n a nti­
rill/·i1lntory prope rly is undollLlt~dly present. 
The sunl(' pi ct ure was ~ho"vn by P y r a m i d u []. In 
this cnsc a ll th e \ C\ lucs fel! to ze ro, l>oth ror filHill a tion 
nnd r)()s t- libriil n tion . f il a ta tion 01 the h ea rt occurred 
s iJ1Hdlnnco lls ly with the lFl. ll to ze ro o r H ~ ho rt time 
b e fore iL 
Tlte illCrapeuti ca l d ose a nd the maximum dose are 
close toge the r in th ese two dru gs; a lthough they th e re­
fore posses s a di s tinct Hllti-lilHillntory powe r, both 
:'uh ~ l a ncc" (lre ius t a little too toxi c. 
Afte r Chi 0 r ~ 1 h y d r a t e the values came in three 
of th e five cases to ze ro b oth ror bbrilla tion a nd post­
fibrilla ti on . Thi s fed I rolio","cd suddenly a ft e r the 
va lues h a d remained pracl icaJl y cons ta nt , \v hil s t a t tl1l' 
sa me time rlilntil ti on o f the venlri c lt:s occured . Thi s is 
the re forc a lypi ca l tox ic fa ll 01 the valnes. 
a r d i a z 0 I showed a fHII of til e varues for p ost­
fibrillation to ze ro ill three out 01 th e six expe riments , 
b efore dil a tation of th e ventricl es occured . In two o f 
the s ix ca ses the values a F fibrill a tion al so f 1\ to zero ; 
this , howeve r, a fter the ve nlricles w ere a lready dila ted , 
C a r d i a Z 0 I the refo re h as a nti-fibrill a to ry p rope r­
ties . 
A s , howe\'(~ r . \vith a good nntihbrill a ti o n d rug the 
va lues for post- librill a ti on and also lor fibriHa tion must 
have f"ll en to 1.('10 hefore svmloms o f cardi ac intoxi ­
ca tion occm , Ca r d i a Z0" is al so still too loxic for 
u se a s a comple te tll era peuti c. 
Co [a rn in e yie lded a lall of the va l lies for fibril ­
la tion and post-fibrilla tion to zero in two of th e five 
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experiments . Tn these cases, however, dilatation of the 
ventricles had already previously occurred and the 
cardiac act ion was also pre tty ba d. In this case, too , 
th e antifibri'llatory action is a result of the cardiac 
intoxication . 
Dig'i tal is showed a fall of th e values ror fibrilfa­
tion and post-Fibrillation in two of the cases, the lethal 
dose also being reach ed. H ere ag'ain, therefore, we 
have a toxic fall of th e values, a nd not a specifically 
a ntifibrilfatory dIect. 
Finally it follows from six ex perim ents with S t r 0­
p han t h i n that this drug possesses no anti -fibril­
la tory properties whatever. Afte r lise of this drug' dea th 
occur~ed after the values both for fibrillation and for 
post-fibrillation in most cases had not fallen at all. 
Conclusion 
Th e substances of the Barbituric acid grollp inves tl­

~ated by me possess anti-fibrillatory properties. A s 

th erapeutic drugs th ey are of no use, as the therapeu­

tic dose is larger than th e maximum dose. 

The sa me holds good of Ant i p Y r i n. P y ram i­

don, and Cor ami n e. 

In th e case of Di g ita J i sand C h ! 0 r a I-h y­





Afte r a th erapeutic close of C a I'd i a Z 0 i no post­

fibrillation ca n be bro ught about, whilst this is possible 





S t r 0 p han t h i n a nd !\ n tip Y r j n in a lethal 

dose C<:luse d e<:l th from ventricle fibrillation. 

The fact that in all my experiments. in which Stro­

phanthin was u sed , death occurred from ventricular 
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fibrillation . I consider Lo be or importance clinically. 

For caution is necessa ry with intravenous slrophan­

thin injections nol only when digitalis hus been ad­

ministered shortly be lore. but also when th e palient is 

not under tIl e influence of dig·itali s. 

Cases have beell observed in which. under those co n­





The stales or co llarse ""hieh may occur after oral ad­

I.nillistmtion or antipyrine ure also seen in iI new lig'ht 

af"tf'r my illv('~tigation . 

A Sllbst,lIlCC may there Fore be eHective as HIl nnti ­

Fihrillntory drug in therarwulic dose '. if these doses 

are smaller l·han th e maximum dose. i. e. th e dos(~ at 

which loxic e FFect is hrought about. The greater the 

difFerence lwlwee n lhf~ two is, the' better the anh­

f'ibrillaiorv prope rlies Hre. 

~1any sllbstnnces possess anti-fibrillanting prope rti es 

whe n the maximum dose is exceeded . that is. only 

"vhen th e dose is toxic. 
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